Evidence map›Paper›PMID 25848957›Full record

ArticlePloS one2015

Methylene blue protects astrocytes against glucose oxygen deprivation by improving cellular respiration.

Gourav Roy Choudhury, Ali Winters, Ryan M Rich, Myoung-Gwi Ryou, Zygmunt Gryczynski, Fang Yuan, Shao-Hua Yang, Ran Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutics of Alzheimer's Disease: Recent Developments.Antioxidants (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Gourav Roy ChoudhuryDepartment of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Ali WintersDepartment of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Ryan M RichDepartment of Cell Biology & Immunology, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Myoung-Gwi RyouDepartment of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Zygmunt GryczynskiDepartment of Cell Biology & Immunology, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Fang YuanDepartment of Neurosurgery, Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Shao-Hua YangDepartment of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America; Department of Neurosurgery, Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Ran LiuDepartment of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
University of North Texas · USUniversity of North Texas Health Science Center · USBeijing Institute of Neurosurgery · CNCapital Medical University · CN

Funding

Neuroglobin: cell metabolism and neuroprotectionR01NS088596 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2014 to 2018
$1.6M
Vascular Cognitive Impairment Induced by Ischemic Stroke: mechanism and therapyR01NS054651 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2008 to 2012
$1.6M
Establishment of inducible astrocyte specific p38 MAPK knockout mouse lineR21NS087209 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2014 to 2015
$402k
NINDS NIH HHS NS054651NINDS NIH HHS NS087209NINDS NIH HHS NS088596NINDS NIH HHS R01 NS054651NINDS NIH HHS R01 NS088596NINDS NIH HHS R21 NS087209
6 · The paper itself

Abstract

Astrocytes outnumber neurons and serve many metabolic and trophic functions in the mammalian brain. Preserving astrocytes is critical for normal brain function as well as for protecting the brain against various insults. Our previous studies have indicated that methylene blue (MB) functions as an alternative electron carrier and enhances brain metabolism. In addition, MB has been shown to be protective against neurodegeneration and brain injury. In the current study, we investigated the protective role of MB in astrocytes. Cell viability assays showed that MB treatment significantly protected primary astrocytes from oxygen-glucose deprivation (OGD) & reoxygenation induced cell death. We also studied the effect of MB on cellular oxygen and glucose metabolism in primary astrocytes following OGD-reoxygenation injury. MB treatment significantly increased cellular oxygen consumption, glucose uptake and ATP production in primary astrocytes. In conclusion our study demonstrated that MB protects astrocytes against OGD-reoxygenation injury by improving astrocyte cellular respiration.

Indexed as

Adenosine TriphosphateAnimalsAstrocytesCell HypoxiaCell RespirationCells, CulturedCell SurvivalCytoprotectionDrug Evaluation, PreclinicalGlucoseGlycogenHexokinaseMethylene BlueMice, Inbred C57BLNeuroprotective AgentsOxygenAdenosine TriphosphateGlucoseGlycogenHexokinaseMethylene BlueNeuroprotective AgentsOxygen

Identifiers

PMID25848957
PMCPMC4388695
OpenAlexW1979786394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.